COMPASS Pathways(CMPS) Stock Price Today

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Stifel Maintains COMPASS Pathways(CMPS.US) With Buy Rating, Maintains Target Price $11
Moomoo NewsApr 11 13:31 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Argenx Se (ARGX) and COMPASS Pathways (CMPS)
TipRanksApr 11 06:51 ET · Ratings
Morgan Stanley Maintains COMPASS Pathways(CMPS.US) With Buy Rating, Maintains Target Price $17
Moomoo NewsApr 2 13:31 ET · Ratings
Morgan Stanley Remains a Buy on COMPASS Pathways (CMPS)
TipRanksApr 2 10:45 ET · Ratings
This Is a Test From GlobeNewswire
GlobeNewswireMar 28 17:01 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Compass Pathwaysto Overweight
BenzingaMar 28 10:12 ET

Comments

Teddy123

Mar 26 18:34

Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression

$COMPASS Pathways (CMPS.US)$
Breakthrough Depression Treatment Reaches Critical Phase 3 Milestone: COMP360 Psilocybin Trial Fully Enrolled

Jaguar8

Mar 26 18:30

NEWS

$COMPASS Pathways (CMPS.US)$
Compass Pathways Announces Completion of Recruitment for the Phase 3 COMP005 Trial of COMP360 Psilocybin for Treatment-Resistant Depression
Wednesday, 26th March at 6:30 am
Highlights:
• Screening closed for all sites and final participants being scheduled for dosing
• On track for top-line 6-week primary endpoint results in late Q2
Compass Pathways plc (NASDAQ: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation,...

Teddy123

Mar 18 18:34

Compass Pathways Announces Publication of Results from COMP004 Study on COMP360 Psilocybin for Treatment-Resistant Depression

$COMPASS Pathways (CMPS.US)$
Breakthrough: Single Dose Psilocybin Fights Depression for 189 Days, New Study Shows

1

Teddy123

Feb 27 19:41

Compass Pathways Announces Fourth Quarter and Full-Year 2024 Financial Results and Business Highlights

$COMPASS Pathways (CMPS.US)$
Can Compass Pathways' $140M Cash Infusion Offset Growing Losses in Psychedelic Treatment Race?

Jaguar8

Feb 6 11:20

🟤 Watchlist, FEBRUARY 6,2025,Thursday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...

57

12

1

CMPS COMPASS Pathways

Trade Overview

Capital Trend

News

Comments

Market Insights

Latest News

Investment Course

Discussing

Earnings Season Underway